Zinc Orotate 60 mg

Name: Zinc Orotate 60 mg
Brand: Advanced Research

BrandAdvanced Research→Mineral Tablet or Pill 9 ingredients 2 caution DSLD #273597

Net contents: 200 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2023-03-22

2 Ingredients (9)

IngredientGroupSafety

ZincZincUse with Caution

Magnesium CarbonateMagnesiumUse with Caution

Microcrystalline CelluloseCellulose—

silicified Microcrystalline CelluloseSilicified microcrystalline cellulose—

natural GlazeCoating—

Cellulose GumCellulose—

Glyceryl BehenateGlyceryl behenate—

PovidonePovidone—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Zinc — Chronic zinc >40 mg/day without copper causes copper deficiency: anemia, neutropenia, myeloneuropathy [1].

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Zinc — Use with Caution

⚠ Copper deficiency at >40 mg/day

⚠ Nausea, metallic taste

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

GLA — Limited Evidence

⚠ May lower seizure threshold

⚠ Borage oil: hepatotoxic unless PA-free

4 Label claims

• All Other

5 Data source

DSLD ID273597

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2023-03-22

6 More from Advanced Research

View Advanced Research Safety Scorecard → 2 products

K-MG

7 Cite this page

Vancouver

Pkhakadze G. Zinc Orotate 60 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 29]. Available from: https://supplement.ge/products/dsld-273597/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG